Valuation: Amedica Corporation

Market Cap 8.03M 7.04M 6.49M 6.08M 11.4M 758M 11.64M 78.04M 30.2M 375M 30.17M 29.51M 1.3B P/E 2026 *
-0.87x
P/E 2027 * -1.3x
Enterprise Value 8.03M 7.04M 6.49M 6.08M 11.4M 758M 11.64M 78.04M 30.2M 375M 30.17M 29.51M 1.3B EV / Sales 2026 *
3.49x
EV / Sales 2027 * 1.53x
Free-Float
65.08%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 63 2007-11-30
President - 2026-03-15
Director of Finance/CFO 41 2025-09-03
Director TitleAgeSince
Director/Board Member 63 2007-11-30
Director/Board Member 63 2025-04-02
Director/Board Member 72 2012-11-04
Change 5-day change 1-year change 3-year change Capi.($)
-7.92%-7.29% - - 8.03M
+5.25%+9.06%-14.88%+11.95% 121B
-0.65%+0.53%+3.83%-7.89% 12.85B
+1.30%+10.08%+42.91%+109.94% 8.37B
-3.88%-6.41%-50.89%-72.88% 3.95B
-0.38%-0.97%+16.76%+37.20% 2.53B
-9.06%+10.10%+218.77%+159.71% 1.7B
-8.75%-13.25%-27.64%-24.60% 1.68B
-2.80%-3.48%-2.92%-23.20% 1.57B
Average -2.95%-0.90%+23.24%+23.78% 19.23B
Weighted average by Cap. +3.76%+2.40%-8.01%+14.74%

Financials

2026 *2027 *
Net sales 2.3M 2.02M 1.86M 1.74M 3.27M 217M 3.34M 22.38M 8.66M 107M 8.65M 8.46M 372M 5.27M 4.62M 4.26M 3.99M 7.47M 497M 7.63M 51.17M 19.8M 246M 19.78M 19.35M 852M
Net income -12.38M -10.85M -10M -9.37M -17.56M -1.17B -17.93M -120M -46.53M -577M -46.48M -45.47M -2B -11.38M -9.98M -9.19M -8.61M -16.14M -1.07B -16.48M -111M -42.76M -530M -42.72M -41.79M -1.84B
Net Debt - -
Logo Amedica Corporation
SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-